Bolenol
Bolenol (INN, USAN), also known as 17α-ethyl-19-norandrost-5-en-17β-ol (ethylnorandrostenol), is a synthetic, orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of 19-nortestosterone (nandrolone) that was never marketed.[1] It was described in the literature in 1969.[1]
![]() | |
Clinical data | |
---|---|
Other names | Ethylnorandrostenol; 17α-Ethyl-19-norandrost-5-en-17β-ol |
Routes of administration | By mouth |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
ECHA InfoCard | 100.037.226 ![]() |
Chemical and physical data | |
Formula | C20H32O |
Molar mass | 288.475 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
See also
References
- J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 168–. ISBN 978-1-4757-2085-3.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.